Source: DGNews | Posted 8 years ago
FDA Advisory Committee Unanimously Recommends Approval of Lipid Lowering Drug, Crestor (Rosuvastatin Calcium)
Tags:
WILMINGTON, DE -- July 10, 2003 -- AstraZeneca Pharmaceuticals (NYSE: AZN) announced that the Endocrinologic and Metabolic Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously to recommend approval for Crestor
Comments